...
首页> 外文期刊>Cancer Cell >Integrated breast cancer genomics.
【24h】

Integrated breast cancer genomics.

机译:综合乳腺癌基因组学。

获取原文
获取原文并翻译 | 示例
           

摘要

Predicting survival and therapy responses of breast cancer patients is a significant challenge. Two studies in this issue of Cancer Cell present a novel integrated analysis of genomic and transcriptomic profiles of 145 primary breast cancers and 51 established cell lines. Data from clinical tumors highlighted mechanisms of disease and facilitated identification of potential therapeutic targets and prognostic biomarkers. An extensive well-characterized cancer cell line resource opens up opportunities to explore the determinants of cellular responses to existing and emerging therapies. Taken together, these studies illustrate how integrated molecular profiling may one day significantly impact diagnosis and therapeutic choice in human breast cancer.
机译:预测乳腺癌患者的生存和治疗反应是一项重大挑战。本期《癌细胞》杂志上的两项研究提出了对145种原发性乳腺癌和51种已建立的细胞系的基因组和转录组谱进行新颖的综合分析。来自临床肿瘤的数据突出了疾病的机制,并促进了潜在治疗靶标和预后生物标志物的鉴定。广泛表征的癌细胞系资源为探索细胞对现有和新兴疗法反应的决定因素提供了机会。综上所述,这些研究表明,整合的分子谱分析可能一天如何显着影响人类乳腺癌的诊断和治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号